Synergistic photothermal and antioxidant photo-responsive release hydrogel platform inhibits the IL-17 signaling pathway for osteoarthritis therapy.
This platform synergistically combines controlled drug delivery and PTT, achieving unprecedented integration of IL-17 pathway inhibition with a photothermal-antioxidant system for OA treatment, enables concurrent metabolic reprogramming and structural preservation, offering a novel strategy for disease-modifying OA the...